To further explore correlation between the expression of POLE and survival of HCC patients, the Kaplan-Meier curve with median survival of 1.1 years in the POLEhigh group and 2.8 years in the POLElow group also demonstrated worse PFS of patients with high POLE expression (Figure 3B). Here, POLE is linked to hepatocellular carcinoma.